This capsule is the combined preparation of Carbonyl Iron, Folic Acid and Zinc Sulfate Monohydrate. It contains Carbonyl Iron with not less than 98% Iron content. Carbonyl Iron, having high bioavailability and low toxicity is safer and more effective choice for Iron supplementation.

Indications and Usage:
It is indicated for the treatment and prophylaxis of iron, folic acid and zinc deficiency especially during pregnancy and lactation.

Use in Pregnancy & Lactation:
Use of any drug during the first trimester of pregnancy should be avoided if possible. Thus administration of Iron during the first trimester requires definite evidence of Iron deficiency. Prophylaxis of Iron deficiency where inadequate diet calls for supplementary Zinc and Folic acid is justified during the remainder of pregnancy.

Drug Interactions:
Carbonyl iron may decrease the absorption of tetracycline antibiotics, quinolone antibiotics, levodopa, levothyroxine, methyldopa and penicillamine. Folic acid interacts with antiepileptics no plasma concentrations of phenobarbital, phenytoin and primidone possibly reduced.

Side Effects:
Gastrointestinal irritations such as nausea, anorexia, vomiting, discomfort, constipation and diarrhoea may occur. Patients may complain of dark stool. Carbonyl Iron pellets are incorporated into the capsules to reduce the possibility of gastrointestinal irritations. Rarely there may be allergic reactions.

Contraindications:
It is contraindicated in patients with known hypersensitivity to any of its component or those with Iron overload.

Precautions :
Special care should be taken in patient with iron overload states, such as haemochromatosis, haemolytic anaemia or red cell aplasia. Failure to respond to the treatment requires further investigations to exclude other causes of anaemia. In patients with renal failure there may be the risk of zinc accumulation.

Storage:
Keep away from light, store in a cool and dry place. Keep out of reach of children.